| Literature DB >> 35455286 |
Junjie Aw1,2, Sharna Si Ying Seah1, Benjamin Jun Jie Seng3, Lian Leng Low1,2,4,5.
Abstract
COVID-19 has culminated in widespread infections and increased deaths over the last 3 years. In addition, it has also resulted in collateral economic and geopolitical tensions. Vaccination remains one of the cornerstones in the fight against COVID-19. Vaccine hesitancy must be critically evaluated in individual countries to promote vaccine uptake. We describe a survey conducted in three Singapore community hospitals looking at healthcare workers' vaccine hesitancy and the barriers for its uptake. The online anonymous survey was conducted from March to July 2021 on all staff across three community hospital sites in SingHealth Singapore. The questionnaire was developed following a scoping review and was pilot tested and finalized into a 58-item instrument capturing data on demographics, contextual features, knowledge, attitudes, perceptions, and other vaccine-related factors in the vaccine hesitancy matrix. Logistic regression analysis was employed for all co-variates that are significant in univariate analysis. The response rate was 23.9%, and the vaccine hesitancy prevalence was 48.5% in the initial phase of the pandemic. On logistic regression analysis, only being female, a younger age, not having had a loved one or friend infected with COVID-19 and obtaining information from newspapers were associated with vaccine hesitancy in healthcare workers in Singapore community hospitals.Entities:
Keywords: 2019 novel coronavirus disease; COVID-19; COVID-19 pandemic; COVID-19 vaccines; SARS-CoV-2 infection; Singapore; associations; attitudes; barriers; coronavirus disease-19; healthcare workers; knowledge; perceptions; qualitative; vaccine acceptance; vaccine hesitancy; vaccines
Year: 2022 PMID: 35455286 PMCID: PMC9032808 DOI: 10.3390/vaccines10040537
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X
Sociodemographic profiles of participants.
| Sociodemographics | Total | Vaccine Hesitant | Non-Vaccine Hesitant | |
|---|---|---|---|---|
| Male, n (%) | 50 (21) | 15 (13) | 35 (28) | 0.003 |
| Age ~, median (25th, 75th percentiles) | 33 (29, 40) | 32 (28, 38) | 34 (30, 43) | 0.022 |
| Age groups, n (%) | 0.054 | |||
|
| 184 (76) | 96 (82) | 88 (71) | |
|
| 56 (23) | 21 (18) | 35 (28) | |
| Profession, n (%) | <0.001 * | |||
|
| 63 (26) | 42 (36) | 21 (17) | |
|
| 81 (34) | 44 (38) | 37 (30) | |
|
| 37 (15) | 12 (10) | 25 (20) | |
|
| 60 (25) | 19 (16) | 41 (33) | |
| Income, n (%) | 0.053 | |||
|
| 99 (41) | 43 (37) | 56 (45) | |
|
| 74 (31) | 43 (37) | 31(25) | |
|
| 42 (17) | 23 (19) | 19 (15) | |
|
| 26 (11) | 8 (7) | 18 (15) | |
| Nationality, n (%) | 0.022 | |||
|
| 79 (33) | 30 (26) | 49 (40) | |
|
| 162 (67) | 87 (74) | 75 (60) | |
| Ethnicity, n (%) | 0.048 | |||
|
| 158 (66) | 84 (72) | 74 (60) | |
|
| 83 (34) | 33 (28) | 50 (40) | |
| Ethnicity, n (%) | 0.102 *# | |||
|
| 158 (66) | 84 (72) | 74 (60) | |
|
| 9 (4) | 4 (3) | 5 (4) | |
|
| 12 (5) | 7 (6.0) | 5 (4.0) | |
|
| 62 (26) | 22 (18.8) | 40 (32.3) | |
| Marital status, n (%) | 0.315 #* | |||
|
| 106 (44) | 49 (42) | 57 (46) | |
|
| 130 (54) | 67 (57) | 63 (51) | |
|
| 2 (1) | 1 (1) | 1 (1) | |
|
| 3 (1) | 0 (0) | 3 (2) | |
| Number of child(ren), median (25th, 75th percentiles) | 0 (0, 2) | 0 (0, 2) | 0 (0, 2) | 0.834 |
| Has at least 1 child | 106 (44) | 51 (44) | 55 (44) | 0.905 |
| Education level, n (%) | 0.075 #$ | |||
|
| 14 (6) | 3 (3) | 11 (9) | |
|
| 48 (20) | 27 (23) | 21 (17) | |
|
| 179 (74) | 87 (74) | 92 (74) | |
| Living arrangement, n (%) | 0.007 $ | |||
|
| 15 (6) | 7 (6) | 8 (6) | |
|
| 182 (76) | 98 (84) | 84 (68) | |
|
| 44 (18) | 12 (10) | 32 (26) | |
~ missing data n = 1; * considered significant if p < 0.008; # Fisher exact test applied; $ considered significant if p < 0.0167.
Vaccine hesitancy matrix.
| Vaccine Hesitant | Non-Vaccine Hesitant | ||
|---|---|---|---|
|
| |||
| Presence of loved ones or friends infected with COVID-19, n (%) | 10 (9) | 32 (26) | <0.001 |
| Perceived effectiveness of SCH leadership influence on vaccine uptake, median (25th, 75th percentiles) | 8 (7, 9) | 8 (7, 9) | 0.046 |
|
| |||
| Perceived clarity of organization’s communication, median (25th, 75th percentiles) | 8 (7, 9) | 8 (7.5, 10) | 0.30 |
| Sources of COVID-19 vaccine information, n (%) | |||
|
| 83 (71) | 78 (63) | 0.19 |
|
| 65 (56) | 65 (52) | 0.63 |
|
| 26 (22) | 14 (11) | 0.023 |
|
| 46 (39) | 42 (34) | 0.38 |
|
| 62 (53) | 58 (47) | 0.34 |
|
| 44 (38) | 30 (24) | 0.024 |
|
| 58 (50) | 49 (40) | 0.12 |
|
| 20 (17) | 14 (11) | 0.20 |
|
| 3 (3) | 1 (1) | 0.36 |
|
| |||
|
| |||
| Perceived helpfulness of protective measures in protecting self from getting infected. | 8 (7, 9) | 8 (7, 9) | 0.54 |
| Agreement with the COVID-19 regulations (e.g., safe-distancing and mask wearing) in place. | 10 (8, 10) | 10 (8, 10) | 0.91 |
| Belief in achieving herd immunity towards the COVID-19 virus even if he/she does not get vaccinated. | 5 (2, 7) | 3 (1,6) | 0.003 |
| Perceived possibility of contracting COVID-19 virus without being vaccinated. | 6 (5, 8) | 7 (5, 9) | 0.10 |
| Confidence in COVID-19 vaccination’s ability to protect self from the COVID-19 virus after vaccination. | 7 (6, 8) | 8 (7, 9) | 0.003 |
| Confidence in COVID-19 vaccination’s ability to confer protection against the COVID-19 virus to loved ones and friends after their vaccination. (0 = Not confident at all, 10 = Extremely confident) | 7 (6, 8) | 8 (7, 9) | 0.004 |
| Self-perceived knowledge of the COVID-19 and its symptoms. | 8 (7, 8) | 8 (7, 9) | 0.054 |
| Felt being coerced into COVID-19 vaccination, n (%) | 21 (18) | 8 (6) | 0.006 |
|
| |||
| Perceived capability of Singapore’s medical system in handling another outbreak. | 8 (7, 9) | 8 (7, 9) | 0.54 |
| Trust in Singapore’s health authorities (e.g., Ministry of Health) in making decisions in the population’s best interest in terms of the COVID-19 vaccines provided. | 9 (7, 10) | 9 (8, 10) | 0.09 |
| Perceived transparency of the authorities on information about safety of the COVID-19 vaccines. | 7 (6, 9) | 8 (7, 9) | 0.002 |
|
| |||
| Does work require direct contact with COVID-19 patients?, n (%) | <0.001 | ||
|
| 109 (93) | 93 (75) | |
|
| 8 (7) | 31 (25) | |
| Perceived eventual duration of the pandemic, n (%) | 0.10 | ||
|
| 20 (17) | 35 (28) | |
|
| 77 (66) | 67 (54) | |
|
| 20 (17) | 22 (18) | |
| Perceived severity of COVID-19 situation in Singapore, median (25th, 75th percentiles) | 5 (3, 6) | 5 (3, 7) | 0.46 |
| Perceived likelihood of loved ones and friends getting infected by COVID-19, median (25th, 75th percentiles) | 6 (4, 8) | 5.5 (4, 7) | 0.78 |
| Perceived time taken to recover from COVID-19 and its possible complications | 0.274 | ||
|
| 12 (10) | 12 (10) | |
|
| 17 (15) | 20 (16) | |
|
| 26 (22) | 40 (32) | |
|
| 62 (53) | 52 (42) | |
| Perceived extent of life being affected once infected by COVID-19 virus, median (25th, 75th percentiles) | 8 (7, 10) | 8 (7, 10) | 0.63 |
| Degree of being emotionally affected (feeling afraid or scared) from the possibility of contracting the COVID-19 virus, median (25th, 75th percentiles) | 8 (5, 9) | 7 (5, 8) | 0.61 |
|
| |||
| Voluntarily taken other vaccination (e.g., flu vaccine or Human Papilloma Virus) previously, n (%) | 83 (71) | 94 (76) | 0.39 |
|
| |||
| Perceived likelihood of taking any vaccine (e.g., flu or Human Papilloma Virus) if offered free and at a convenient place, median (25th, 75th percentiles) | 9 (8, 10) | 10 (9, 10) | < 0.001 |
|
| |||
| “I am concerned about the vaccine’s efficacy” | 0.541 | ||
|
| 78 (66.7) | 78 (62.9) | |
|
| 39 (33.3) | 46 (37.1) | |
| “Country in which vaccine is manufactured forms part of my concerns” | 0.955 | ||
|
| 27 (23.1) | 29 (23.4) | |
|
| 90 (76.9) | 95 (76.6) | |
| “I will decide against taking a particular COVID-19 vaccine if there is distrust in the manufacturer” | 0.59 | ||
|
| 54 (46) | 53 (43) | |
|
| 63 (54) | 71 (57) | |
| “I believe generally in vaccines” | 0.111 # | ||
|
| 5 (4.3) | 1 (0.8) | |
|
| 112 (95.7) | 123 (99.2) | |
| “l am worried about experiencing allergic reactions and/or anaphylaxis” | 0.107 | ||
|
| 65 (55.6) | 56 (45.2) | |
|
| 52 (44.4) | 68 (54.8) | |
| “I am worried about all side effects” | 0.866 | ||
|
| 61 (52.1) | 66 (53.2) | |
|
| 56 (47.9) | 58 (46.8) | |
| Long term side (LT) effects * | 0.016 | ||
|
| 46 (43.4) | 34 (28.1) | |
|
| 60 (56.6) | 87 (71.9) | |
| Sensitivity analyses LT side effects if missing data are all “no I do not have LT side effects concerns” | 0.05 | ||
|
| 46 (39.3) | 34 (27.4) | |
|
| 71 (60.7) | 90 (72.6) | |
| Sensitivity analyses LT side effects if missing data are all “yes I have LT side effects concerns” | 0.003 | ||
|
| 57 (49) | 37 (30) | |
|
| 60 (51) | 87 (70) | |
* missing data n = 14, # Fisher’s exact test applied. SCH, SingHealth Community Hospitals.
Odds ratios of covariates on COVID-19 vaccination acceptance.
| Covariates | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | ||
|---|---|---|---|---|
| Male | 2.67 (1.37–5.22) | 0.004 | 2.44 (1.03–5.78) | 0.043 |
| Age (years) | 1.03 (1.01–1.06) | 0.014 | 1.06 (1.02–1.10) | 0.002 |
| Profession | ||||
|
| Reference Group | - | - | - |
|
| 1.68 (0.85–3.33) | 0.135 | 1.98 (0.82–4.75) | 0.13 |
|
| 4.17 (1.75–9.9) | 0.001 | 2.50 (0.82–7.58) | 0.11 |
|
| 4.32 (2.03–9.18) | <0.001 | 1.56 (0.52–4.64) | 0.43 |
| Nature of work being COVID-19 patient fronting | 4.54 (1.99–10.4) | <0.001 | 2.38 (0.77–7.35) | 0.13 |
| Nationality | ||||
|
| Reference Group | - | - | - |
|
| 0.53 (0.30–0.91) | 0.023 | 1.53 (0.56–4.10) | 0.41 |
| Living arrangement | ||||
|
| Reference Group | - | - | - |
|
| 0.75 (0.26–2.15) | 0.59 | 0.25 (0.06–1.07) | 0.06 |
|
| 2.33 (0.69–7.84) | 0.171 | 1.08 (0.23–4.99) | 0.92 |
| Presence of loved ones or friends infected with COVID-19 | 3.72 (1.74–7.98) | 0.001 | 4.90 (1.68–14.27) | 0.004 |
| Felt coerced into getting COVID-19 vaccination | 0.32 (0.13–0.74) | 0.008 | 1.04 (0.32–3.44) | 0.95 |
| Transparency in information | 1.26 (1.08–1.47) | 0.003 | 1.19 (0.95–1.49) | 0.13 |
| Sources of COVID-19 vaccine information | ||||
|
| 0.47 (0.23–0.95) | 0.025 | 0.48 (0.18–1.26) | 0.14 |
|
| 0.53 (0.30–0.92) | 0.025 | 0.34 (0.16–0.72) | 0.005 |
| Belief in achieving herd immunity towards the COVID-19 virus even if he/she does not get vaccinated | 0.88 (0.81–0.96) | 0.003 | 0.92 (0.83–1.03) | 0.14 |
| Confidence in COVID-19 vaccination’s ability to protect self after vaccination | 1.29 (1.1–1.51) | 0.002 | 1.32 (0.86–2.03) | 0.21 |
| Confidence in COVID-19 vaccination’s ability to protect loved ones and friends after their vaccination | 1.25 (1.07–1.45) | 0.004 | 0.87 (0.59–1.28) | 0.48 |
| Perceived likelihood of taking any vaccine if offered free and at a convenient place | 1.34 (1.14–1.57) | <0.001 | 1.12 (0.94–1.35) | 0.21 |
| Concerned about long term side effects from COVID-19 vaccination | 0.51 (0.29–0.89) | 0.017 | 0.78 (0.38–1.60) | 0.50 |
OR, odds ratio. CI, confidence intervals.